Authors: Wollenberg, A, Flohr, C, Simon, Dagmar, Cork, M J, Thyssen, J P, Bieber, T, de Bruin-Weller, M S, Weidinger, S, Deleuran, M, Taieb, Paul, Trzeciak, Werfel, Seneschal, J, Barbarot, Darsow, U, Torrelo, Stalder, J-F, Svensson, Å, Hijnen, D, Gelmetti, Szalai, Z, Gieler, De Raeve, L, Kunz, B, Spuls, P, von Kobyletzki, L B, Fölster-Holst, R, Chernyshov, P V, Christen-Zaech, Heratizadeh, Ring, Vestergaard

Venue: Journal of the European Academy of Dermatology and Venereology

Type: Publication

Abstract: Atopic dermatitis (AD) is a complex disease with elevated risk of respiratory comorbidities.1,2 Severely affected patients are often treated with immune-modulating systemic drugs.3,4 On March 11th 2020, the World Health Organization declared the 2019 novel coronavirus severe acute respiratory syndrome (SARS-Cov-2) epidemic to be a pandemic. The number of cases worldwide is increasing exponentially and poses a major health threat, especially for those who are elderly, immuno-compromised, or have comorbidities. This also applies to AD patients on... (read more)

DOI: 10.48350/149467 (Found 2 versions)